Viewing Study NCT06434350


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2026-01-04 @ 4:54 AM
Study NCT ID: NCT06434350
Status: RECRUITING
Last Update Posted: 2025-08-14
First Post: 2024-05-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module